Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (“DDS”) and welcomes KKR as joint sh
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
Les 10 meilleur entreprises, cabinets et consultants en recrutement à Andrésy, Yvelines
Alliance Pharma Appoints Patrick Bennett as Chief Executive Officer | Ampersand Capital
Alliance Pharma Expands Bioanalytical Services | Contract Pharma
Alliance Pharma Appoints Patrick Bennett as Chief Executive Officer
News - Alliance Pharma | Ryan Klein
Ampersand Capital Partners Invests in Syft Technologies | citybiz
News - Alliance Pharma | Ryan Klein
Jennifer Berlin - Administrative Assistant - Fisher cunnane & Associates | LinkedIn
Présentation Activa Capital
Alliance Pharma to acquire LGC's Drug Development Solutions business, with KKR as joint shareholder - Bioanalysis Zone
Branden Berns on LinkedIn: It's official. The new year has been an excellent occasion to reflect on… | 114 comments
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
Kugan Sathiyanandarajah on LinkedIn: Alliance Pharma + Drug Development Solutions
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
Ampersand Capital Partners på LinkedIn: U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into…
Ampersand Portfolio Company U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business | Ampersand Capital
In the News
Ampersand Invests in Alliance Pharma, Leading Bioanalytical CRO
Ampersand Invests in Alliance Pharma, Leading Bioanalytical CRO
À propos de nous - Nexelis, a Q² Solutions Company
Alliance in the News - Ampersand
